Daniel R. Hart
2020
Compensation breakdown
| Non-Equity Incentive Plan | $46,396 |
|---|---|
| Option Awards | $210,837 |
| Salary | $396,106 |
| Stock Awards | $142,433 |
| Other | $46,371 |
| Total | $842,143 |
Hart received $396.1K in salary, accounting for 47% of the total pay in 2020.
Hart also received $46.4K in non-equity incentive plan, $210.8K in option awards, $142.4K in stock awards and $46.4K in other compensation.
Rankings
In 2020, Daniel R. Hart's compensation ranked 9,294th out of 13,090 executives tracked by ExecPay. In other words, Hart earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,294 out of 13,090 | 29th |
Division Manufacturing | 3,969 out of 5,621 | 29th |
Major group Chemicals And Allied Products | 1,613 out of 2,254 | 28th |
Industry group Drugs | 1,411 out of 1,954 | 28th |
Industry Pharmaceutical Preparations | 1,034 out of 1,459 | 29th |
Pay ratio
| Daniel R. Hart's Pay | $842,143 |
|---|---|
| Median Employee's Pay | $83,115 |
| Pay Ratio | 10to 1 |
In 2020, the annual total compensation of Daniel R. Hart was $842,143.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $83,115.
The ratio of Daniel R. Hart's pay to the pay of median employee was therefore 10 to one.
Hart's colleagues
We found three more compensation records of executives who worked with Daniel R. Hart at Peregrine Pharmaceuticals in 2020.
News
August 28, 2023
August 29, 2022
August 27, 2021
August 27, 2020
August 21, 2019